Celldex Therapeutics, Inc. · NASDAQ:CLDX

BlackRock, Inc. reported a 7.30% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed Apr 17, 2025

BlackRock, Inc. reported a 7.30% stake in Celldex Therapeutics, Inc., 4,819,293 shares, as a passive investor on Mar 31, 2025. Filed Apr 17, 2025 (Schedule 13G/A).

Stake
7.30%
Shares
4,819,293
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.7.30%4,819,293

Source

View original at SEC

Related